Citation: | WANG Wei-tao, ZHAO Jin-kang, MA Xing. Analysis of curative effect of 26 cases of pigmented villonodular synovitis of knee joint[J]. Chinese Journal of General Practice, 2021, 19(12): 1991-1994. doi: 10.16766/j.cnki.issn.1674-4152.002218 |
[1] |
BERNTHAL N M, ISHMAEL C R, BURKE Z D C. Management of pigmented villonodular synovitis (PVNS): An orthopedic surgeon's perspective[J]. Current Oncology Reports, 2020, 22(6): 63-68. doi: 10.1007/s11912-020-00926-7
|
[2] |
李瑞, 李鸿斌, 薛文贵, 等. 33例色素沉着绒毛结节性滑膜炎回顾性分析[J]. 内蒙古医科大学学报, 2020, 42(2): 193-196, 213. https://www.cnki.com.cn/Article/CJFDTOTAL-NMYX202002021.htm
|
[3] |
DAMODAR D, CHAN N, KOKOT N. Pigmented villonodular synovitis of the temporomandibular joint: Case report and review of the literature[J]. Head Neck, 2015, 37(12): 194-199. doi: 10.1002/hed.24056
|
[4] |
STEPHAN S R, SHALLOP B, LACKMAN R, et al. Pigmented villonodular synovitis: A comprehensive review and proposed treatment algorithm[J]. JBJS Rev, 2016, 4(7): e3.
|
[5] |
VACA M, POLO R, MARTINEZ-SAN-MILLAN J, et al. Pigmented villonodular synovitis of the temporomandibular joint with petrous bone invasion[J]. Otol Neurotol, 2017, 38(5): 58-59. doi: 10.1097/MAO.0000000000001390
|
[6] |
丁振禹, 何耀华. 色素沉着绒毛结节性滑膜炎诊治进展[J]. 国际骨科学杂志, 2017, 38(2): 79-82. doi: 10.3969/j.issn.1673-7083.2017.02.004
|
[7] |
GOUIN F, NOAILLES T. Localized and diffuse forms of tenosynovial giant cell tumor (formerly giant cell tumbor of the tendon sheath and pigmented villonodular synovitis)[J]. Orthop Traumatol Surg Res, 2017, 103(1S): S91-S97.
|
[8] |
FALEK A, NIEMUNIS-SAWICKA J, WRONA K, et al. Pigmented villonodular synovitis[J]. Folia Med Cracov, 2018, 58(4): 93-104.
|
[9] |
COSSEDDU F, SHYTAJ S, SACCHETTI F, et al. Malignant pigmented villonodular synovitis: A brief literature review and case report[J]. Clin Cases Miner Bone Metab, 2020, 16(2): 181-185. http://www.researchgate.net/publication/338735804_Malignant_pigmented_villonodular_synovitis_a_brief_literature_review_and_case_report
|
[10] |
AL FARII H, ZHOU S, TURCOTTE R. The surgical outcome and recurrence rate of tenosynovial giant cell tumor in the elbow: A literature review[J]. Shoulder Elbow Surg, 2019, 28(9): 1835-1840. doi: 10.1016/j.jse.2019.05.007
|
[11] |
任翠, 朱巧, 郎宁, 等. 膝关节弥漫性滑膜病变的MRI诊断及鉴别诊断[J]. 实用放射学杂志, 2020, 36(4): 615-619. doi: 10.3969/j.issn.1002-1671.2020.04.027
|
[12] |
TRITSCHLER P, BAUDREZ V, MUTIJIMA E. Diffuse pigmented villonodular synovitis of the subtalar joint[J]. J Belg Soc Radiol, 2018, 102: 11-12.
|
[13] |
MASTBOOM M J L, V ERSPOOR F G M, V ERSCHOOR A J, et al. Higher incidence rates than previously known in tenosynovial giant cell tumors[J]. Acta Orthop, 2017, 88(6): 688-694. doi: 10.1080/17453674.2017.1361126
|
[14] |
CHANG J S, HIGGINS J P, KOSY J D, et al. Systematic arthroscopic treatment of diffuse pigmented villonodular synovitis in the knee[J]. Arthrosc Tech, 2017, 6(5): e1547-e1551. doi: 10.1016/j.eats.2017.06.029
|
[15] |
康真. 色素沉着绒毛结节性滑膜炎术后放疗的临床观察[J]. 影像研究与医学应用, 2020, 4(22): 208-209. doi: 10.3969/j.issn.2096-3807.2020.22.109
|
[16] |
AVCI G G. The Importance and side effects of radiotherapy for diffuse pigmented villonodular synovitis; Case reports and literature review[J]. Acta Oncologica Turcica, 2020, 53(1): 162-165. doi: 10.5505/aot.2020.42744
|
[17] |
BENNER B, GOOD L, QUIROGA D, et al. Pexidartinib, a novel small molecule csf-1r inhibitor in use for tenosynovial giant cell tumor: A systematic review of pre-clinical and clinical development[J]. Drug Des Devel Ther, 2020, 14: 1693-1704. doi: 10.2147/DDDT.S253232
|
[18] |
STAALS E L, FERRARI S, DONATI D M, et al. Diffuse-type tenosynovial giant cell tumour: Current treatment concepts and future perspectives[J]. Eur J Cancer, 2016, 63: 34-40. http://www.researchgate.net/profile/Emanuela_Palmerini/publication/303815275_Diffuse-type_tenosynovial_giant_cell_tumour_Current_treatment_concepts_and_future_perspectives/links/575d2d4508aec91374ad2b15.pdf
|